27.02.2024 • NewsAir LiquideSasolEnel

Air Liquide and Sasol Sign Renewable Energy Supply Deal in South Africa

French industrial gases company Air Liquide and South African energy company Sasol have signed a power purchase agreements (PPAs) with Enel Green Power for the long term supply of an additional capacity of 110 MW of renewable power to Sasol’s Secunda site in South Africa.

This is the fourth set of PPAs signed by Air Liquide and Sasol after those announced in 2023, the companies said. Together, these PPAs represent a total renewable power capacity of around 690 MW. For Air Liquide, these contracts will represent an annual reduction in its CO2 emissions of approximately 1.2 million t, and contribute to its targeted reduction by 30% to 40% of the CO2 emissions associated with oxygen production in Secunda by 2031.

As part of this agreement, Enel Green Power will create a local company which will build a wind farm located in the Eastern Cape province. This renewable energy production facility is scheduled to be operational by 2026.

Nicolas Poirot, CEO of Air Liquide Africa Middle-East & India, said: “These new renewable electricity supply agreements are yet another sign of our strong joint commitment to decarbonize the production of oxygen in Secunda since Air Liquide took over Sasol’s units in 2021. These long-term contracts will actively support the development of renewable energy in South Africa, for the benefit of the country’s electrical system and ultimately of the South African society in the context of a just transition.”

Air Liquide acquired Sasol’s 16 oxygen production units in Secunda and has been operating them since June 2021, in the framework of a long-term supply contract with its partner. Including another air separation unit (ASU) it already operated for Sasol, Air Liquide operates a total of 17 ASUs in Secunda, with a total capacity of 47,000 t/d of oxygen.

© David Jones/iStockphoto
© David Jones/iStockphoto

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.